These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29676011)

  • 1. Editorial: the impact of steatosis on liver stiffness quantification is minimal.
    Hassan A; Tapper EB
    Aliment Pharmacol Ther; 2018 May; 47(10):1416-1417. PubMed ID: 29676011
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: the impact of steatosis on liver stiffness quantification is minimal-Authors' reply.
    Karlas T; Petroff D; Wiegand J
    Aliment Pharmacol Ther; 2018 May; 47(10):1417-1418. PubMed ID: 29676009
    [No Abstract]   [Full Text] [Related]  

  • 3. Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C.
    Conti F; Serra C; Vukotic R; Fiorini E; Felicani C; Mazzotta E; D'Errico A; Verucchi G; Lenzi M; Andreone P
    Liver Int; 2017 Feb; 37(2):187-195. PubMed ID: 27369740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy?
    Yoon JH; Lee JM; Suh KS; Lee KW; Yi NJ; Lee KB; Han JK; Choi BI
    Radiology; 2015 Aug; 276(2):453-64. PubMed ID: 25763828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Sánchez-Conde M; Montes Ramírez ML; Bellón Cano JM; Caminoa A; Alvarez Rodríguez F; González Garcia J; Miralles Martín P; Bernardino de la Serna I; Bernardo de Quirós JC; Arribas López JR; Cosín Ochaíta J; Pascual Pareja JF; Alvarez E; Berenguer JB
    J Viral Hepat; 2011 Jul; 18(7):e278-83. PubMed ID: 21129129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis.
    Ziol M; Kettaneh A; Ganne-Carrié N; Barget N; Tengher-Barna I; Beaugrand M
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1261-8. PubMed ID: 19478678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Magnetic resonance imaging for quantifying hepatis steatosis and hepatic fibrosis].
    Van Beers B
    Bull Mem Acad R Med Belg; 2009; 164(1-2):44-50; discussion 51-2. PubMed ID: 19718953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography.
    Deffieux T; Gennisson JL; Bousquet L; Corouge M; Cosconea S; Amroun D; Tripon S; Terris B; Mallet V; Sogni P; Tanter M; Pol S
    J Hepatol; 2015 Feb; 62(2):317-24. PubMed ID: 25251998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement.
    Karlas T; Petroff D; Sasso M; Fan JG; Mi YQ; de Lédinghen V; Kumar M; Lupsor-Platon M; Han KH; Cardoso AC; Ferraioli G; Chan WK; Wong VW; Myers RP; Chayama K; Friedrich-Rust M; Beaugrand M; Shen F; Hiriart JB; Sarin SK; Badea R; Lee HW; Marcellin P; Filice C; Mahadeva S; Wong GL; Crotty P; Masaki K; Bojunga J; Bedossa P; Keim V; Wiegand J
    Aliment Pharmacol Ther; 2018 Apr; 47(7):989-1000. PubMed ID: 29446106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals.
    Noureddin M; Wong MM; Todo T; Lu SC; Sanyal AJ; Mena EA
    World J Gastroenterol; 2018 Mar; 24(11):1269-1277. PubMed ID: 29568207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steatosis and liver stiffness measurements using transient elastography.
    Eddowes P; Sasso M; Fournier C; Vuppalanchi R; Newsome P
    Hepatology; 2016 Aug; 64(2):700. PubMed ID: 26928747
    [No Abstract]   [Full Text] [Related]  

  • 12. Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan.
    Roulot D; Roudot-Thoraval F; NKontchou G; Kouacou N; Costes JL; Elourimi G; Le Clesiau H; Ziol M; Beaugrand M
    Liver Int; 2017 Dec; 37(12):1897-1906. PubMed ID: 28556413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison.
    Poynard T; Pham T; Perazzo H; Munteanu M; Luckina E; Elaribi D; Ngo Y; Bonyhay L; Seurat N; Legroux M; Ngo A; Deckmyn O; Thabut D; Ratziu V; Lucidarme O;
    PLoS One; 2016; 11(10):e0163276. PubMed ID: 27706177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B.
    Cai YJ; Dong JJ; Wang XD; Huang SS; Chen RC; Chen Y; Wang YQ; Song M; Chen YP; Li Z; Zhou MT; Shi KQ
    J Viral Hepat; 2017 Nov; 24(11):1005-1015. PubMed ID: 28419755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.
    Sasso M; Miette V; Sandrin L; Beaugrand M
    Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):13-20. PubMed ID: 21920839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
    Karlas T; Berger J; Garnov N; Lindner F; Busse H; Linder N; Schaudinn A; Relke B; Chakaroun R; Tröltzsch M; Wiegand J; Keim V
    World J Gastroenterol; 2015 Apr; 21(16):4894-902. PubMed ID: 25945002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study.
    Alferink LJM; Fittipaldi J; Kiefte-de Jong JC; Taimr P; Hansen BE; Metselaar HJ; Schoufour JD; Ikram MA; Janssen HLA; Franco OH; Darwish Murad S
    J Hepatol; 2017 Aug; 67(2):339-348. PubMed ID: 28578837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease.
    Leitão HS; Doblas S; Garteiser P; d'Assignies G; Paradis V; Mouri F; Geraldes CF; Ronot M; Van Beers BE
    Radiology; 2017 Apr; 283(1):98-107. PubMed ID: 27788034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.